Jabbour Jerome D 4

What Happened
Jerome D. Jabbour, a director of Indaptus Therapeutics, was granted options to purchase 25,000 shares of common stock on 2026-02-26. The Form 4 reports the award as a derivative acquisition with $0.00 listed (no cash paid at grant). This is an equity compensation grant, not a sale or an exercise of options.

Key Details

• Transaction date: 2026-02-26; Form 4 filed 2026-02-27 (timely filing).
• Transaction type/code: Award/Grant (A); derivative instrument = stock options.
• Quantity: options to purchase 25,000 shares. Price reported: $0.00 (no cash exchanged at grant).
• Vesting: Options vest over three years commencing on the grant date, in equal quarterly installments, subject to continued board service (per footnote).
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: Grant granted pursuant to the issuer's non-employee director compensation program.

Context
Option grants to directors are common as part of board compensation and do not represent an immediate purchase of shares. Any future exercise of these options or subsequent sale of shares would be reported separately and could have different implications for insider sentiment. The vesting schedule ties the award to continued board service, so the options are not all immediately exercisable.